Browse studies, page 411

Page 411 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Acid-suppressive effect of tegoprazan 12.5 mg BID: a phase 1 comparative study with tegoprazan 25 mg QD and famotidine 20 mg BID. Translational and clinical pharmacology, 2025
• Tegoprazan-Amoxicillin Dual Therapy Versus Bismuth Quadruple Therapy Versus Tegoprazan-Based Quadruple Therapy for Helicobacter pylori Eradication: A Network Meta-Analysis Cureus, 2026
• Anti-Inflammatory Effects of Tegoprazan in Lipopolysaccharide-Stimulated Bone-Marrow-Derived Macrophages International journal of molecular sciences, 2023
• A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory Drugs Gut and liver, 2026
• Efficacy and safety of tegoprazan- and rabeprazole-based concomitant therapies for Helicobacter pylori infection: Real-world evidence Journal of gastroenterology and hepatology, 2024
• Comparison of tegoprazan and proton pump inhibitors for first-line Helicobacter pylori eradication: a systematic review with meta-analysis Expert review of anti-infective therapy, 2025
• Tegoprazan: a novel, highly selective, and potent potassium-competitive acid blocker (P-CAB) European journal of clinical pharmacology, 2025
• Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole British journal of clinical pharmacology, 2022
• The Role of P-CABs in GERD. The American journal of gastroenterology, 2025
• Tegoprazan Versus Proton Pump Inhibitors for Erosive Esophagitis: A Meta-Analysis of Noninferiority Randomized Controlled Trials JGH open : an open access journal of gastroenterology and hepatology, 2025
• Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy Pharmaceutics, 2022
• GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach Molecules, 2021
• Diagnostic approaches of pneumonia for commercial-scale biomedical applications: an overview All Life, 2020
• Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors Plants, 2022
• Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli Antibiotics, 2021
• Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients with COVID -19 Journal of Pharmaceutical Negative Results, 2022
• Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter? Clinical Infectious Diseases, 2005
• Correspondence on: ‘Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation—an open-label cohort study’ by Della-Torre et al Annals of the Rheumatic Diseases, 2020
• Serum Procalcitonin and Outcomes in Severe Pediatric Pneumonia: A Secondary Analysis of An Observational Multicenter Study Journal of the Pediatric Infectious Diseases Society, 2026
• Nonoperative treatment with antibiotics versus surgery for acute nonperforated appendicitis in children: a pilot randomized controlled trial Annals of Surgery, 2015
• A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer New England Journal of Medicine, 2015
• A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood Brain, behavior, and immunity, 2015
• Beyond the Randomized Controlled Trial: A Review of Alternatives in mHealth Clinical Trial Methods JMIR mHealth and uHealth, 2016
• A Randomized Controlled Trial of the Tumor Necrosis Factor-alpha Antagonist Infliximab in Treatment Resistant Depression: Role of Baseline Inflammatory Biomarkers JAMA psychiatry, 2013
• Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial Rheumatology, 2018
• Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS-RCT) American Heart Journal, 2019
• Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial Circulation, 2022
• Anticoagulation Therapy 2016
• Integrated (Meta) Genomic and Synthetic Biology Approaches to Develop New Biocatalysts Marine Drugs, 2016
• Evaluation of the Impact of Different Pain Medication and Proton Pump Inhibitors on the Osteogenic Differentiation Potential of hMSCs Using 99mTc-HDP Labelling Life, 2021
• Method Development Technology and Optimisation Studies in Famotidine Pellets: An In Vitro Release Journal of Positive School Psychology, 2022
• A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors Advances in Therapy, 2017
• Онтологический подход к развитию креативности как основа когнитивной образовательной технологии Вестник Тюменского государственного университета. Социально-экономические и правовые исследования, 2013
• Meta-analysis of the transcriptome identifies aberrant RNA processing as common feature of aging in multiple species Molecules and Cells, 2024
• Association of Down syndrome with periodontal diseases: Systematic review and meta-analysis Special Care in Dentistry: managing special patients, settings, and situations, 2023
• Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis Journal of Infection, 2020
• aPTT-guided anticoagulation monitoring during ECMO support: A systematic review and meta-analysis Journal of critical care, 2023
• The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis EClinicalMedicine, 2022
• Radiofrequency Catheter Ablation Improves the Quality of Life Measured with a Short Form-36 Questionnaire in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis PLoS ONE, 2016
• First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis Clinical Gastroenterology and Hepatology, 2020
• Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update Journal of Clinical Oncology, 2023
• Exposure to ambient air pollution and the incidence of dementia: A population-based cohort study Environment International, 2017
• Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014 The British journal of psychiatry : the journal of mental science, 2017
• A hospital-wide evaluation of delirium prevalence and outcomes in acute care patients - a cohort study BMC Health Services Research, 2018
• Short‐term outcomes of multicenter prospective cohort study of gastric endoscopic resection: ‘Real‐world evidence’ in Japan Digestive Endoscopy, 2018
• Mental health outcomes at the end of the British involvement in the Iraq and Afghanistan conflicts: a cohort study The British journal of psychiatry : the journal of mental science, 2018
• Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study BMJ Open, 2018
• Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry) British medical journal, 2018
• Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study British medical journal, 2018
• Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants British medical journal, 2018
• Association of Lipids With Ischemic and Hemorrhagic Stroke: A Prospective Cohort Study Among 267 500 Chinese Stroke, 2019
• Clinical and Biological Predictors of Response to Standardised Paediatric Colitis Therapy: A Multicentre Inception Cohort Study The Lancet, 2019
• Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study Diabetes Care, 2020
• Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study Thorax, 2020
• A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality Antimicrobial Agents and Chemotherapy, 2020
• Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study Clinical Gastroenterology and Hepatology, 2020
• Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study The Lancet Microbe, 2020
• Patient Satisfaction With Telemedicine During the COVID-19 Pandemic: Retrospective Cohort Study Journal of Medical Internet Research, 2020
• Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study medRxiv, 2020
• Consumption of coffee and tea and risk of developing stroke, dementia, and poststroke dementia: A cohort study in the UK Biobank PLoS Medicine, 2021
• Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study The Lancet Respiratory Medicine, 2021
• Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study British medical journal, 2021
• Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study The Lancet Respiratory Medicine, 2021
• Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study British medical journal, 2022
• Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study The Lancet, 2020
• A Dose-Response Efficacy and Safety Study of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD) Who Are Incomplete Responders to a Proton Pump Inhibitor (PPI) ClinicalTrials.gov · COMPLETED, 2010
• A Phase 3, Randomized, Double-Blind, Double Dummy, Multicenter, Parallel Group Comparison Study to Evaluate Efficacy and Safety of a Triple Therapy With TAK-438, Amoxicillin and Clarithromycin by Comparison With a Triple Therapy With AG-1749 (Lansoprazole), Amoxicillin and Clarithromycin for the First Line Eradication of H.Pylori ClinicalTrials.gov · COMPLETED, 2013
• Helicobacter Pylori Treatment ClinicalTrials.gov · COMPLETED, 2012
• Prospective Study of the Effects of Helicobacter Pylori Eradication on Renal Functions and Proteinuria in Patients With Membranous Nephropathy ClinicalTrials.gov · COMPLETED, 2009
• A Phase I, Open-Label Study to Assess the Pharmacokinetics and Relative Bioavailability of AZD4635 in Non-Smoking Healthy Male Subjects, With the Option to Assess Food Effect, pH Effect and Absolute Bioavailability ClinicalTrials.gov · COMPLETED, 2019
• Effect of Prevacid on Prostaglandin Levels in the Gastric Mucosa of Patients With Stress Ulcer ClinicalTrials.gov · COMPLETED, 2007
• Prospective, Randomized Controlled Trial Comparing Amoxicillin and Metronidazole Based Bismuth-containing Quadruple Therapy With Amoxicillin and Clarithromycin Based Quadruple Therapy for First-line Helicobacter Pylori Eradication ClinicalTrials.gov · COMPLETED, 2015
• Helicobacter Pylori Eradication Rates of Concomitant Therapy and Tailored Therapy Based on 23S Ribosomal RNA Point Mutations Associated With Clarithromycin Resistance: A Multicenter Prospective Randomized Study ClinicalTrials.gov · COMPLETED, 2019
• Comparative Recurrence Rate Investigation of Esomeprazole Versus Lansoprazole in Triple-Combination Therapy to Eradicate Helicobacter Pylori Infection Among Pediatrics: Multicentre, Randomized, and Controlled Trials ClinicalTrials.gov · COMPLETED, 2022
• Safety and Efficacy of Lansoprazole in Patients With Reflux Disease. An Open, Single Arm, Long-term Study ClinicalTrials.gov · COMPLETED, 2008
• Combination Therapy With Sitagliptin (DPP 4 Inhibitor) and Lansoprazole (PPI) Inhibitor) to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes ClinicalTrials.gov · COMPLETED, 2015
• A Phase 1, Single- and Repeated-Dose, Randomized, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Lansoprazole in Infants With Clinically-Evident Gastroesophageal Reflux Disease ClinicalTrials.gov · COMPLETED, 2005
• A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE ClinicalTrials.gov · TERMINATED, 2026
• Randomized Placebo-Controlled Trial of BID Lansoprazole in Isolated Chronic Post Nasal Drip ClinicalTrials.gov · COMPLETED, 2008
• A Phase 1, Randomized, Open-Label, Parallel Group, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole Modified Release Capsules (30 mg and 60 mg) in Adolescents With Symptomatic Gastroesophageal Reflux Disease ClinicalTrials.gov · COMPLETED, 2009
• A Phase 1, Randomized, Open-Label, Single-Center, Single-Dose, Two-Period Two-Part Crossover Study in Healthy Subjects to Compare the Bioavailability of Dexlansoprazole From Dexlansoprazole Delayed-Release Capsules 30 mg and 60 mg Manufactured by Takeda GmbH Plant Oranienburg Relative to Dexlansoprazole Delayed-Release Capsules 30 mg and 60 mg Manufactured by Takeda Pharmaceutical Company Limited Osaka Plant ClinicalTrials.gov · COMPLETED, 2017
• A Phase II Trial of Broad Spectrum Antibiotic Therapy for Early Stage, Non-progressive Chronic Lymphocytic Leukaemia Without Adverse Prognostic Factors ClinicalTrials.gov · COMPLETED, 2016
• A Phase 1, Open-Label Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric pH Modification on the Pharmacokinetics of MLN1117 in Healthy Subjects ClinicalTrials.gov · COMPLETED, 2016
• Open Label, Randomized, Two-treatment, Three-period, Three-sequence, Partial Replicate Oral Bioequivalence Study of Lansoprazole 30 mg DR Capsules of Dr.Reddy's Laboratories Limited, India Comparing With That of PREVACID® (Containing Lansoprazole) 30 mg DR Capsules of TAP Pharmaceuticals Inc. USA, in Healthy, Adult, Human Subjects Under Fasting Conditions ClinicalTrials.gov · COMPLETED, 2008
• Phase I Study to Investigate Pharmacodynamics of CJ-12420 Compared to Dexlansoprazole With Evening Dosing ClinicalTrials.gov · COMPLETED, 2015
• A Prospective Randomized Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program at Eskenazi Hospital ClinicalTrials.gov · COMPLETED, 2019
• A Phase 3, Multicenter, Single-blind, AG-1749-controlled, Parallel-group, Long-term Extension Study to Evaluate the Safety and Efficacy of TAK-438 (10 mg or 20 mg, Orally, Once Daily) for the Prevention of Recurrent Gastric or Duodenal Ulcers During Long-term Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) ClinicalTrials.gov · COMPLETED, 2013
• Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed ClinicalTrials.gov · COMPLETED, 2004
• The Effects of Gastro-esophageal Acid Suppression on Post-tonsillectomy Pain ClinicalTrials.gov · TERMINATED, 2011
• A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD) ClinicalTrials.gov · COMPLETED, 2006
• Comparative Study of 2% Chlorhexidine Gluconate in 70% Isopropyl Alcohol Against 10% Sodium Hypochlorite as Skin Antiseptics in Human Volunteers ClinicalTrials.gov · COMPLETED, 2012
• A Randomized, Double-Blind, Phase 3 Study to Compare the Efficacy and Safety of Lansoprazole 30 mg QD and Naproxen 500 mg BID Versus Celecoxib 200 mg QD in Risk Reduction of Non Steroidal Anti-Inflammatory-Associated Ulcers in Osteoarthritis Subjects Taking Low Dose Aspirin ClinicalTrials.gov · COMPLETED, 2004
• Long-Term Study of the Efficacy and Safety of Lansoprazole in the Treatment of Zollinger-Ellison and Other Acid Hypersecretors ClinicalTrials.gov · COMPLETED, 2010
• A Phase Ⅲ Multi-center, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Ilaprazole (20mg QD) in Adult Patients With Erosive Esophagitis ClinicalTrials.gov · COMPLETED, 2011
• The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer ClinicalTrials.gov · COMPLETED, 2022
• Comparing the Efficacy and Impact on Gastrointestinal Microbiota of Reverse Hybrid Therapy and Concomitant Therapy in Helicobacter Pylori Eradication ClinicalTrials.gov · COMPLETED, 2020
• Effect of Rabeprazole and Lansoprazole on Reflux Esophagitis in Relation to CYP2C19 Genotype Status: A Prospective, Randomized, Multicenter Study ClinicalTrials.gov · COMPLETED, 2008
• A Multi-center, Randomized, Double-blind, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of LXI-15028 Compared to Lansoprazole in the Treatment of Duodenal Ulcer in Chinese Patients for up to 6 Weeks ClinicalTrials.gov · COMPLETED, 2022
• Additive Effect of Endonase on the Efficacy of Bismuth-containing Quadruple Therapy as Second-line Treatment for Helicobacter Pylori Infection ClinicalTrials.gov · TERMINATED, 2013
• A Phase 3, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Tegoprazan 25 mg for the Prevention of Peptic Ulcer Disease in Patients on Continuous Long-term Treatment With NSAIDs ClinicalTrials.gov · COMPLETED, 2025